Dr. Mark Bleackley

Dr. Mark Bleackley

Articles by Dr. Mark Bleackley

Dr. Mark BleackleyRheumatology | February 2, 2024
Incannex announces the first dosing in a phase 2 study of a novel drug combination comprising HCQ and CBD to treat RA.
View More